Effect of transforming growth factor β2 on oestrogen metabolism in the MCF-7 breast cancer cell line

被引:5
作者
Erbas, H [1 ]
Lai, LC [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Dept Clin Biochem & Metab Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
transforming growth factor beta(2); oestrone sulphatase; oestradiol-17 beta hydroxysteroid dehydrogenase; breast cancer;
D O I
10.1136/jcp.53.4.322
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Transforming growth factor beta (TGF-B) is a multifunctional regulator of cellular growth and differentiation in many cell types and has a growth inhibitory effect on mammary epithelial cells. The TGF-beta(2) isoform has been shown to be present in high concentrations in breast cyst fluid and might have a protective role in breast cancer. In addition, oestrogens play an important role in breast cancer development, and oestrone sulphate (E1S) might be the main source of active oestrogens in the breast. The aim of this study was to assess the effect of TGF-beta(2) on oestrogen synthesis in an attempt to understand the mechanism by which TGF-beta(2) may exert a protective effect in breast cancer. In this study, higher concentrations of TGF-beta(2) significantly inhibited the conversion of E1S to oestrone (E-1) and the conversion of E-1 to the potent oestrogen, oestradiol (E-2). TGF-beta(2) did not have any effect on MCF-7 cell growth or on E-2 to E-1 conversion. In conclusion, TGF-beta(2) might exert a protective role in breast cancer by reducing the amount of active oestrogens present in the breast.
引用
收藏
页码:322 / 324
页数:3
相关论文
共 10 条
[1]  
ARRICK BA, 1990, CANCER RES, V50, P299
[2]   Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen [J].
Benson, JR ;
Wakefield, LM ;
Baum, M ;
Colletta, AA .
BRITISH JOURNAL OF CANCER, 1996, 74 (03) :352-358
[3]  
Ee YS, 1999, ONCOL REP, V6, P843
[4]  
JAMES VHT, 1980, HORMONES CANCER, P471
[5]   EVIDENCE THAT TRANSFORMING GROWTH-FACTOR-BETA IS A HORMONALLY REGULATED NEGATIVE GROWTH-FACTOR IN HUMAN-BREAST CANCER-CELLS [J].
KNABBE, C ;
LIPPMAN, ME ;
WAKEFIELD, LM ;
FLANDERS, KC ;
KASID, A ;
DERYNCK, R ;
DICKSON, RB .
CELL, 1987, 48 (03) :417-428
[6]  
LAI LC, 1994, ANTICANCER RES, V14, P2805
[7]   TYPE-BETA TRANSFORMING GROWTH-FACTOR - A BIFUNCTIONAL REGULATOR OF CELLULAR GROWTH [J].
ROBERTS, AB ;
ANZANO, MA ;
WAKEFIELD, LM ;
ROCHE, NS ;
STERN, DF ;
SPORN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (01) :119-123
[8]   INSITU ESTROGEN PRODUCTION VIA THE ESTRONE SULFATASE PATHWAY IN BREAST-TUMORS - RELATIVE IMPORTANCE VERSUS THE AROMATASE PATHWAY [J].
SANTNER, SJ ;
FEIL, PD ;
SANTEN, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (01) :29-33
[9]   SOME RECENT ADVANCES IN THE CHEMISTRY AND BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
SPORN, MB ;
ROBERTS, AB ;
WAKEFIELD, LM ;
DECROMBRUGGHE, B .
JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1039-1045
[10]   EFFECTS OF TGF-BETA ON NORMAL AND MALIGNANT MAMMARY EPITHELIUM [J].
ZUGMAIER, G ;
LIPPMAN, ME .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 593 :272-275